0
0
0
SACKLER Act
3/13/2024, 5:20 PM
Summary of Bill S 2831
The SACKLER Act, also known as Bill 118 s 2831, is a piece of legislation introduced in the US Congress. The purpose of this bill is to hold pharmaceutical companies accountable for their role in the opioid crisis. The bill specifically targets the Sackler family, who are the owners of Purdue Pharma, the company responsible for manufacturing OxyContin.
The SACKLER Act aims to impose a tax on the profits made by pharmaceutical companies from the sale of opioids. This tax would be used to fund programs and initiatives aimed at addressing the opioid crisis, such as addiction treatment and prevention programs.
Additionally, the bill seeks to prevent the Sackler family from profiting off of the sale of opioids by requiring them to pay back any profits made from the sale of OxyContin. This would help ensure that those responsible for fueling the opioid crisis are held accountable for their actions. Overall, the SACKLER Act is a bipartisan effort to address the devastating impact of the opioid crisis and hold pharmaceutical companies accountable for their role in perpetuating it.
The SACKLER Act aims to impose a tax on the profits made by pharmaceutical companies from the sale of opioids. This tax would be used to fund programs and initiatives aimed at addressing the opioid crisis, such as addiction treatment and prevention programs.
Additionally, the bill seeks to prevent the Sackler family from profiting off of the sale of opioids by requiring them to pay back any profits made from the sale of OxyContin. This would help ensure that those responsible for fueling the opioid crisis are held accountable for their actions. Overall, the SACKLER Act is a bipartisan effort to address the devastating impact of the opioid crisis and hold pharmaceutical companies accountable for their role in perpetuating it.
Read the Full Bill
Current Status of Bill S 2831
Bill S 2831 is currently in the status of Bill Introduced since September 18, 2023. Bill S 2831 was introduced during Congress 118 and was introduced to the Senate on September 18, 2023. Bill S 2831's most recent activity was Read twice and referred to the Committee on the Judiciary. as of September 18, 2023
Bipartisan Support of Bill S 2831
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
4Democrat Cosponsors
4Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 2831
Primary Policy Focus
Finance and Financial SectorAlternate Title(s) of Bill S 2831
SACKLER Act
SACKLER Act
Stop shielding Assets from Corporate Known Liability by Eliminating non-debtor Releases Act
A bill to prohibit the non-consensual release of claims by States, municipalities, federally recognized Tribes, or the United States against non-debtors, and for other purposes.
Comments
Sponsors and Cosponsors of S 2831
Latest Bills
National Law Enforcement Officers Remembrance, Support, and Community Outreach Act
Bill HR 309August 21, 2026
National Oceanic and Atmospheric Administration Sexual Harassment and Assault Prevention Improvements Act of 2025
Bill HR 2406August 21, 2026
No Antisemitism in Education Act of 2026
Bill HR 8476August 21, 2026
Chesapeake Bay Watershed Advancement for Training, Education, Restoration, and Science (WATERS) Act
Bill HR 6893August 21, 2026
To provide for the equitable settlement of certain Indian land disputes regarding land in Illinois, and for other purposes.
Bill HR 2827August 21, 2026
Local Communities & Bird Habitat Stewardship Act of 2026
Bill HR 3276August 21, 2026
To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
Bill HR 4541August 20, 2026
Stop Insider Trading Act
Bill HR 7008August 20, 2026
National Defense Authorization Act for Fiscal Year 2027
Bill HR 8800August 20, 2026
Main Street Capital Access Act
Bill HR 6955August 20, 2026